GO:0002862 negative regulation of inflammatory response to antigenic stimulus: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002862 describes any process that stops, prevents, or reduces the frequency, rate, or extent of an inflammatory response to an antigenic stimulus.
• The term is a biological_process node that sits at the intersection of innate immune sensing, cytokine signaling, and resolution of inflammation.
• Key negative regulators include anti-inflammatory cytokines, checkpoint phosphatases, and decoy receptors that dampen antigen-driven NF-kB and MAPK signaling.
• Dysregulation of this process is linked to recurrent spontaneous abortion, chronic inflammatory disease, and tumor-promoting inflammation.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are the primary tools for causally testing candidate negative regulators.
• EDITGENE provides end-to-end cell model engineering and CRISPR library screening to dissect this pathway at scale.
Description
GO:0002862, negative regulation of inflammatory response to antigenic stimulus, is a Gene Ontology biological_process term that captures the active suppression of inflammation triggered by an antigen. In practical terms, it is the brake that prevents an immune reaction to a foreign or self antigen from becoming excessive, chronic, or tissue-destructive. This process is essential for immune homeostasis and is a major research focus because its failure underlies autoimmunity, pregnancy loss, and cancer-related inflammation. Mechanistically, negative regulation of inflammatory response to antigenic stimulus is executed by a network of anti-inflammatory cytokines, intracellular phosphatases, and signaling adaptors that terminate or attenuate NF-kB, MAPK, and STAT-dependent inflammatory programs. Understanding which molecules enforce this brake, and how, is central to identifying therapeutic targets and diagnostic biomarkers. This article synthesizes the QuickGO definition with verified PubMed literature to provide a research-grade overview of the term, its genes, disease links, and experimental methods.
negative regulation of inflammatory response to antigenic stimulus At A Glance
| GO ID | GO:0002862 |
|---|---|
| GO term | negative regulation of inflammatory response to antigenic stimulus |
| Ontology | biological_process |
| Synonym | down regulation of inflammatory response to antigenic stimulus; down-regulation of inflammatory response to antigenic stimulus; downregulation of inflammatory response to antigenic stimulus; inhibition of inflammatory response to antigenic stimulus |
| Major function | Suppression or attenuation of inflammation triggered by an antigenic stimulus |
| Biological context | Innate and adaptive immune regulation, resolution of inflammation, immune tolerance |
| Representative regulators | Anti-inflammatory cytokines, MAPK phosphatases, NF-kB inhibitors, decoy receptors |
| Disease relevance | Recurrent spontaneous abortion, chronic inflammatory disease, cancer progression |
What Is GO:0002862?
According to the QuickGO definition, GO:0002862 refers to any process that stops, prevents, or reduces the frequency, rate, or extent of an inflammatory response to an antigenic stimulus. In other words, it is the set of molecular and cellular events that actively restrain antigen-driven inflammation rather than initiate it. The term is a biological_process and is synonymous with down regulation, down-regulation, downregulation, and inhibition of inflammatory response to antigenic stimulus.
Why Is negative regulation of inflammatory response to antigenic stimulus Important in Cell Biology?
Negative regulation of inflammatory response to antigenic stimulus is important because unchecked antigen-driven inflammation causes tissue damage, autoimmunity, and pregnancy loss, while excessive suppression permits infection and tumor progression. The balance enforced by this process determines whether an immune response resolves or becomes chronic, making it a central node for therapeutic intervention.
• Prevents excessive tissue damage from antigen-driven inflammation.
• Maintains immune tolerance and prevents autoimmunity.
• Is dysregulated in recurrent spontaneous abortion.
• Shapes the tumor microenvironment and cancer progression.
• Controls macrophage responses to LPS and other antigenic stimuli.
• Involves anti-inflammatory dietary and metabolic modulation.
• Is regulated by MAPK and NF-kB inhibitory pathways.
• Provides biomarkers such as LYN and CYBB for immune-related diagnosis.
• Is a target for anti-inflammatory drug discovery.
• Can be modeled with CRISPR knockout and knock-in cell systems.
What Happens During negative regulation of inflammatory response to antigenic stimulus?
Antigen Sensing and Initial Inflammatory Trigger
In simple terms: First, the immune system detects an antigen and starts an inflammatory alarm.
Antigenic stimuli such as LPS or foreign proteins activate innate effector cells including macrophages and dendritic cells, initiating inflammatory signaling. This initial trigger is necessary for host defense but must be tightly controlled to avoid collateral damage. The macrophage response towards LPS is a well-characterized model of this antigen-driven activation.
Activation of Negative Regulatory Checkpoints
In simple terms: Next, dedicated brake molecules are switched on to limit the alarm.
Negative regulation of inflammatory response to antigenic stimulus is enforced by intracellular checkpoints such as 14-3-3 proteins, which inhibit microglial activation via the NF-kB pathway. Similarly, the p38(MAPK)-STAT3 axis controls the macrophage response to LPS and provides a node for negative regulation. These checkpoints prevent runaway cytokine production.
Suppression of Pro-inflammatory Cytokine Output
In simple terms: The brakes reduce the production of inflammatory cytokines.
Anti-inflammatory signals such as Irisin inhibit MAPK pathway activation in LPS-stimulated macrophages, reducing pro-inflammatory cytokine release. This suppression is a direct manifestation of negative regulation of inflammatory response to antigenic stimulus. The balance between activating and inhibitory signals determines the final inflammatory output.
Resolution and Return to Homeostasis
In simple terms: Finally, the inflammation is resolved and the tissue returns to normal.
Resolution involves active termination of inflammatory signaling and restoration of tissue homeostasis. Coagulation and inflammation are interconnected, and negative regulation helps prevent thrombosis driven by excessive inflammation. Failure of resolution contributes to chronic inflammatory disease.
Key Genes Involved in GO:0002862 negative regulation of inflammatory response to antigenic stimulus
The following genes and proteins are experimentally implicated in negative regulation of inflammatory response to antigenic stimulus or in the inflammatory pathways it controls.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LYN | Immune and inflammatory signaling kinase | Diagnostic biomarker in recurrent spontaneous abortion |
| CYBB | NADPH oxidase subunit in phagocytes | Diagnostic biomarker in recurrent spontaneous abortion |
| STAT3 | Transcription factor downstream of p38(MAPK) | Controls macrophage response to LPS |
| MAPK14 (p38) | Stress-activated kinase | Central to LPS-induced macrophage activation |
| NFKB1 | Master inflammatory transcription factor | Target of 14-3-3-mediated inhibition |
| YWHAB (14-3-3) | Negative regulator of NF-kB | Inhibits microglial activation |
| FNDC5 (Irisin) | Anti-inflammatory myokine | Inhibits MAPK in LPS-stimulated macrophages |
| IL10 | Anti-inflammatory cytokine | Dampens antigen-driven inflammation |
| TGFB1 | Immunosuppressive cytokine | Promotes resolution of inflammation |
| SOCS1 | Cytokine signaling suppressor | Limits inflammatory cytokine signaling |
| SOCS3 | Cytokine signaling suppressor | Modulates STAT3-dependent inflammation |
| DUSP1 | MAPK phosphatase | Terminates p38/MAPK signaling |
| TNFAIP3 (A20) | NF-kB inhibitor | Restrains antigen-driven NF-kB activation |
| NFKBIA (IkBa) | NF-kB inhibitor | Sequesters NF-kB in cytoplasm |
| CD24 | Immune checkpoint molecule | Modulates antigen-driven inflammation |
| SIGLEC10 | Inhibitory receptor | Dampens innate effector cell activation |
| VSIR (VISTA) | Negative immune checkpoint | Regulates inflammatory responses |
How Is negative regulation of inflammatory response to antigenic stimulus Regulated?
Negative regulation of inflammatory response to antigenic stimulus is itself regulated at multiple levels. The p38(MAPK)-STAT3 axis integrates stress and cytokine signals to control macrophage inflammatory output. 14-3-3 proteins negatively regulate microglial activation by inhibiting the NF-kB pathway, providing a direct molecular brake. Anti-inflammatory metabolic and dietary factors can also modulate this process. Coagulation pathways intersect with inflammatory regulation, and their crosstalk influences the extent of the response.
negative regulation of inflammatory response to antigenic stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LYN | Recurrent spontaneous abortion | Knockout and overexpression in trophoblast or immune cells |
| CYBB | Recurrent spontaneous abortion | Point-mutation and knockout in macrophages |
| YWHAB (14-3-3) | Neuroinflammation | Knockout in microglial cell lines |
| FNDC5 (Irisin) | Metabolic inflammation | Overexpression in LPS-stimulated macrophages |
| STAT3 | Chronic inflammatory disease | Knock-in of phospho-mutant in macrophages |
Recurrent Spontaneous Abortion
LYN and CYBB have been identified as pivotal immune and inflammatory genes and diagnostic biomarkers in recurrent spontaneous abortion, linking dysregulated negative regulation of inflammatory response to antigenic stimulus to pregnancy loss.
Cancer and Tumor-Promoting Inflammation
Innate effector cells play both positive and negative roles in controlling cancer progression, and the balance of inflammatory regulation influences tumor outcomes. Excessive or unresolved inflammation can promote tumorigenesis, whereas effective negative regulation supports anti-tumor immunity.
Chronic Inflammatory and Metabolic Disease
Anti-inflammatory diets and metabolic modulators such as Irisin can attenuate antigen-driven inflammation, suggesting that lifestyle and metabolic interventions can influence this process. Dysregulation contributes to chronic inflammatory states.
Neuroinflammation
14-3-3 proteins negatively regulate microglial activation via NF-kB inhibition, and loss of this brake contributes to neuroinflammatory pathology. The spleen has also been described as a neuroimmune interface after spinal cord injury, highlighting systemic regulation of inflammation.
From negative regulation of inflammatory response to antigenic stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is gene X a negative regulator of antigen-driven inflammation? | CRISPR knockout cell line followed by LPS stimulation |
| Does a specific phosphorylation site control the brake function? | Point-mutation knock-in of phospho-dead or phospho-mimetic allele |
| Can a candidate regulator be tagged for localization studies? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of an anti-inflammatory factor suppress inflammation? | Overexpression cell model in macrophages |
| Which pathways mediate the negative regulation? | CRISPR library screening with cytokine readouts |
| Can biomarkers be validated in disease context? | Patient-derived cells with knockout/knock-in |
How to Study the negative regulation of inflammatory response to antigenic stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes | Identify anti-inflammatory gene signatures |
| Cytokine ELISA | Secreted TNF, IL-6, IL-10 | Quantify inflammatory output |
| CRISPR knockout screen | Gene requirement for negative regulation | Discover novel brakes |
| Western blot | Phospho-NF-kB and phospho-p38 levels | Confirm pathway inhibition |
| Co-immunoprecipitation | Protein-protein interactions | Validate 14-3-3 binding |
| NF-kB luciferase reporter | NF-kB transcriptional activity | Measure negative regulation |
| Immunofluorescence | Subcellular localization of NF-kB | Visualize pathway suppression |
| Flow cytometry | Immune cell activation markers | Assess innate effector function |
Transcriptomic and Cytokine Profiling
RNA-seq and cytokine arrays measure the inflammatory output of cells after antigenic stimulation, revealing the impact of negative regulators. These methods are used to quantify changes in TNF, IL-6, and IL-10 upon knockout or overexpression.
CRISPR Screening and Functional Genomics
Pooled CRISPR knockout screens identify genes that negatively regulate inflammatory response to antigenic stimulus, using survival or reporter-based readouts. This approach enables unbiased discovery of brakes in the pathway.
Protein Interaction and Signaling Analysis
Co-immunoprecipitation, Western blotting, and phospho-specific antibodies are used to dissect NF-kB and MAPK signaling changes. These methods confirm whether a candidate regulator acts through 14-3-3, STAT3, or MAPK nodes.
Imaging and Reporter Assays
NF-kB luciferase reporters and immunofluorescence imaging visualize the activation state of inflammatory pathways in live cells. These assays are used to validate negative regulation in real time.
How CRISPR Can Be Used to Study GO:0002862 negative regulation of inflammatory response to antigenic stimulus
Knockout
CRISPR knockout of candidate genes such as LYN, CYBB, or YWHAB tests whether they are required for negative regulation of inflammatory response to antigenic stimulus. Loss of function typically increases inflammatory cytokine production after antigenic stimulation.
Point Mutation
Point-mutation knock-in of phospho-dead or phospho-mimetic residues in STAT3 or NFKBIA dissects the precise signaling events that enforce negative regulation. This approach distinguishes catalytic from scaffolding functions.
Knock-in
Tagged knock-in of endogenous loci with fluorescent or epitope tags enables real-time tracking of negative regulators during antigenic stimulation. This preserves physiological expression levels.
Overexpression
Overexpression of anti-inflammatory factors such as FNDC5 (Irisin) or 14-3-3 proteins suppresses LPS-induced inflammatory signaling, providing gain-of-function evidence for negative regulation.
How EDITGENE Supports negative regulation of inflammatory response to antigenic stimulus Research
Researchers studying negative regulation of inflammatory response to antigenic stimulus-related genes often need to determine whether a candidate gene is causally involved in suppressing antigen-driven inflammation, and CRISPR-engineered cell models provide the most direct way to test this.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of inflammatory response to antigenic stimulus research.
Frequently Asked Questions About negative regulation of inflammatory response to antigenic stimulus
What is GO:0002862?
GO:0002862 is the Gene Ontology term for negative regulation of inflammatory response to antigenic stimulus, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of an inflammatory response to an antigenic stimulus.
What genes are involved in negative regulation of inflammatory response to antigenic stimulus?
Genes such as LYN, CYBB, STAT3, MAPK14, NFKB1, YWHAB, FNDC5, IL10, and TNFAIP3 have been implicated in this process or the pathways it controls.
How is negative regulation of inflammatory response to antigenic stimulus studied?
It is studied using CRISPR knockout, point-mutation, knock-in, and overexpression cell models combined with RNA-seq, cytokine assays, and signaling analysis.
Why is negative regulation of inflammatory response to antigenic stimulus important in disease?
Dysregulation is linked to recurrent spontaneous abortion, chronic inflammatory disease, neuroinflammation, and cancer progression.
What is the role of 14-3-3 proteins in this process?
14-3-3 proteins negatively regulate microglial activation by inhibiting the NF-kB pathway, acting as a direct brake on antigen-driven inflammation.
How does the p38-MAPK-STAT3 axis contribute?
The p38(MAPK)-STAT3 axis controls the macrophage response to LPS and provides a node through which negative regulation of inflammatory response to antigenic stimulus is enforced.
Can diet influence negative regulation of inflammatory response to antigenic stimulus?
Anti-inflammatory diets have been reviewed as modulators of inflammatory responses, suggesting lifestyle factors can influence this process.
What biomarkers are associated with this process?
LYN and CYBB have been identified as pivotal immune and inflammatory genes and diagnostic biomarkers in recurrent spontaneous abortion.
What experimental models are best for studying this term?
CRISPR knockout and overexpression models in macrophages or microglia, combined with LPS stimulation, are widely used.
How does EDITGENE support research on this term?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for dissecting negative regulation of inflammatory response to antigenic stimulus.
Conclusion
GO:0002862, negative regulation of inflammatory response to antigenic stimulus, is a critical biological process that restrains antigen-driven inflammation through checkpoints such as 14-3-3, p38-MAPK-STAT3, and anti-inflammatory cytokines. Its dysregulation contributes to recurrent spontaneous abortion, chronic inflammation, and cancer, making it a high-value target for research and therapeutic development. CRISPR-engineered cell models and functional genomics provide the most direct route to causal understanding of this process.
References
- 1. Scheiber A et al.. 2026. Anti-Inflammatory Diets.. PMID: 37983365
- 2. Esmon CT. 2004. The impact of the inflammatory response on coagulation.. Thromb Res 114(5-6):321-7 PMID: 15507261
- 3. Ma Y et al.. 2023. Anti-inflammatory effect of Irisin on LPS-stimulated macrophages through inhibition of MAPK pathway.. Physiol Res 72(2):235-249 PMID: 37159857
- 4. Noble BT et al.. 2018. The spleen as a neuroimmune interface after spinal cord injury.. J Neuroimmunol 321:1-11 PMID: 29957379
- 5. Stolk D et al.. 2018. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.. Front Immunol 9:1990 PMID: 30298063
- 6. Wu Z et al.. 2025. LYN and CYBB are pivotal immune and inflammatory genes as diagnostic biomarkers in recurrent spontaneous abortion.. Front Immunol 16:1568536 PMID: 40692778
- 7. Bode JG et al.. 2012. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis.. Cell Signal 24(6):1185-94 PMID: 22330073
- 8. Stone WJ et al.. 2025. 14-3-3 Proteins Negatively Regulate Microglial Activation via Inhibition of the NF-κB Pathway.. J Neurochem 169(9):e70228 PMID: 40931680
